Intermittent, short infusion Ceftazidime
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
The Alfred
Overview
Intermittent, short infusion Ceftazidime is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Intermittent, short infusion Ceftazidime clinical trials
Explore related
Medical disclaimer. This page summarizes research about Intermittent, short infusion Ceftazidime for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.